Like a tenacious bulldog, Roche Holding AG continues its determined effort to acquire Illumina, Inc., the company that makes gene sequencing systems. Last week, Roche increased its offer from $44.50 per share to $51 per share for Illumina stock. That raises the price Roche says it will pay to $6.5 billion, which is 15% greater […]
April 2, 2012 “Intelligence: Late Breaking Lab News”
- By Robert Michel
- > From the Volume XIX No. 5 - April 2, 2012 Issue
- Tags: american society for clinical pathology, ASCP, clinical lab, clinical lab test, clinical lab testing, Clinical pathology, DarkDaily, gene sequencing, genome sequencing, histopath, histopathology, human genome, human genome sequencing, lab budget, lab test, lab testing, laboratory medicine, laboratory science, medical lab, Medical laboratory, medical laboratory science, Medicare, next-generation gene sequencing, whole human genome sequencing
